Skip to main content
. 2011 Jan 31;6(1):43–50. doi: 10.1159/000324048

Table 4.

Adjuvant endocrine therapy in patients with hormone receptor-positive invasive breast cancer (n = 4,128)

Age, years Adjuvant endocrine therapy, n (%)
< 20 (n = 1) 1 (100)
20–29 (n = 9) 6 (66.7)
30–39 (n = 113) 84 (74.3)
40–49 (n = 554) 383 (69.1)
50–59 (n = 942) 683 (72.5)
60–69 (n = 1,478) 1,086 (73.5)
70–79 (n = 718) 479 (66.7)
80–89 (n = 299) 184 (61.5)
90–99 (n = 14) 5 (35.7)
Total (n = 4,128) 2,911 (70.5)